Next Article in Journal
Can the Mindful Awareness and Resilience Skills for Adolescents (MARS-A) Program Be Provided Online? Voices from the Youth
Next Article in Special Issue
Genetic Predisposition to Neuroblastoma
Previous Article in Journal
Chronic Pediatric Pain in Low- and Middle-Income Countries
Previous Article in Special Issue
Late Effects and Survivorship Issues in Patients with Neuroblastoma
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Children 2018, 5(9), 114; https://doi.org/10.3390/children5090114

High-Risk Neuroblastoma Treatment Review

Baylor College of Medicine Department of Pediatrics, Texas Children’s Cancer and Hematology Center, Houston, TX 77030, USA
*
Author to whom correspondence should be addressed.
Received: 30 June 2018 / Revised: 18 August 2018 / Accepted: 20 August 2018 / Published: 28 August 2018
(This article belongs to the Special Issue Recent Advances in Diagnosis and Treatment of Neuroblastoma)
Full-Text   |   PDF [763 KB, uploaded 28 August 2018]   |  

Abstract

Neuroblastoma is the most common extracranial solid tumor in children. One subset, high-risk neuroblastoma, is very difficult to treat and requires multi-modal therapy. Intensification of therapy has vastly improved survival rates, and research is focused on novel treatments to further improve survival rates. The current treatment schema is divided into three stages—induction, consolidation, and maintenance. This review serves as an overview of the current treatment for high-risk neuroblastoma and a glimpse at current research for future therapy. View Full-Text
Keywords: neuroblastoma; high-risk neuroblastoma; diagnosis; treatment neuroblastoma; high-risk neuroblastoma; diagnosis; treatment
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Smith, V.; Foster, J. High-Risk Neuroblastoma Treatment Review. Children 2018, 5, 114.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Children EISSN 2227-9067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top